A journal article published in 1876 has supported a researcher's suggestion that a decades-old arthritis drug could be a cheap alternative in the treatment of diabetes, the Wall Street Journal reports.
Salsalate, a non-steroidal, anti-inflammatory medication, that is similar to aspirin and does not cause stomach bleeding, has been linked to beneficial results in a modern setting for some time (Marketletter February 11, 2008). Steven Sholeson, a researcher at Joslin Diabetes Center in Massachusetts, USA, found confirmation of his theory that the drug could be used as a cheap alternative in the treatment of type 2 diabetes in a German medical article from the 19th century.
According to the WSJ, the drug blocks a chemical pathway that may provide the link between inflammation and diabetes that has long been sought by researchers. The drug significantly lowered spikes in blood sugar in a set of small trials in around 30 diabetics, with results from a larger study forthcoming.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze